SEC Form 4 · accession 0001209191-15-027277
ARADIGM CORP · ARDM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Juergen Kurt Froehlich
Officer — Chief Medical Officer
Period of report
Mar 13, 2015
Accepted (ET)
Mar 17, 2015 · 7:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013238
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $7.19 | Mar 13, 2015 | A | 25,246 | A | — | Mar 13, 2025 | Common Stock | 25,246 | 25,246 | D |
Explanation of responses
- F1Option vests as to 33-1/3% of the shares on the one-year anniversary of the vesting start date of 3/13/2015 with the remaining shares vesting quarterly over two years thereafter
- F2Inapplicable